Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
A study published in the journal Cancer suggests that women with early-stage breast cancer who have a lumpectomy followed by radiation therapy have at least an equal, if not greater, chance of survival compared with those who have a mastectomy without radiation therapy.
Researchers who presented at the American College of Cardiology’s Annual Scientific Session found that race is associated with the risk of developing heart failure after treatment for breast cancer. Heart failure is weakness of the heart muscle that affects the heart’s ability to pump blood throughout the body.
A Washington state study showed higher bankruptcy rates after a cancer diagnosis, especially among young people.
Fear of recurrence, or fear of cancer coming back, is a common psychological effect among people diagnosed with cancer, during or after treatment. A review of several existing studies now shows that fear of recurrence may last more than 5 years beyond the date of diagnosis, and be felt at nearly the same level of intensity as during the first 5 years.
In a landmark decision, the U.S. Supreme Court unanimously ruled that genes taken from the human body could not be patented.
Women diagnosed with early-stage breast cancer that begins in the lobules of the breast gain just as much benefit from treatment with trastuzumab (Herceptin) as women with early-stage cancer that starts in the ducts of the breast, researchers found.
A study suggests age-specific incidences of breast cancer subtypes vary by race, showing that the differences by race occur only when tumor subtypes are grouped together.
WASHINGTON (Reuters) - In a first of its kind ruling on human genes, a unanimous U.S. Supreme Court on Thursday decided that synthetically produced genetic material can be patented but naturally occurring DNA extracted from the human body cannot.
CHICAGO (Reuters) - Breast cancer is less likely to recur if women previously treated for the disease take the drug tamoxifen for 10 years, instead of the recommended five years, according to a British study.
CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving high rates of especially deadly breast cancer in black women in the United States.